These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21401325)

  • 21. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.
    Buesen R; Chorley BN; da Silva Lima B; Daston G; Deferme L; Ebbels T; Gant TW; Goetz A; Greally J; Gribaldo L; Hackermüller J; Hubesch B; Jennen D; Johnson K; Kanno J; Kauffmann HM; Laffont M; McMullen P; Meehan R; Pemberton M; Perdichizzi S; Piersma AH; Sauer UG; Schmidt K; Seitz H; Sumida K; Tollefsen KE; Tong W; Tralau T; van Ravenzwaay B; Weber RJM; Worth A; Yauk C; Poole A
    Regul Toxicol Pharmacol; 2017 Dec; 91 Suppl 1(Suppl 1):S3-S13. PubMed ID: 28958911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the ecotoxicity data submitted within the framework of the REACH Regulation. Part 1. General overview and data availability for the first registration deadline.
    Sobanska MA; Cesnaitis R; Sobanski T; Versonnen B; Bonnomet V; Tarazona JV; De Coen W
    Sci Total Environ; 2014 Feb; 470-471():1225-32. PubMed ID: 24246945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current developments in reproductive toxicity testing of pesticides.
    Cooper RL
    Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time matters: A stock-pollution approach to authorisation decision-making for PBT/vPvB chemicals under REACH.
    Gabbert S; Hilber I
    J Environ Manage; 2016 Dec; 183():236-244. PubMed ID: 27594688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data.
    Seed J; Carney EW; Corley RA; Crofton KM; DeSesso JM; Foster PM; Kavlock R; Kimmel G; Klaunig J; Meek ME; Preston RJ; Slikker W; Tabacova S; Williams GM; Wiltse J; Zoeller RT; Fenner-Crisp P; Patton DE
    Crit Rev Toxicol; 2005; 35(8-9):664-72. PubMed ID: 16417033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity analysis, dominant factors, and robustness of the ECETOC TRA v3, Stoffenmanager 4.5, and ART 1.5 occupational exposure models.
    Riedmann RA; Gasic B; Vernez D
    Risk Anal; 2015 Feb; 35(2):211-25. PubMed ID: 25616198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The OECD expert meeting on ecotoxicology and environmental fate--towards the development of improved OECD guidelines for the testing of nanomaterials.
    Kühnel D; Nickel C
    Sci Total Environ; 2014 Feb; 472():347-53. PubMed ID: 24461369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of alternative tests for developmental and reproductive toxicology testing: an ILSI Health and Environmental Sciences Institute perspective.
    Kim JH
    Methods Mol Biol; 2013; 947():475-87. PubMed ID: 23138922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI.
    MacDonald J; French JE; Gerson RJ; Goodman J; Inoue T; Jacobs A; Kasper P; Keller D; Lavin A; Long G; McCullough B; Sistare FD; Storer R; van der Laan JW
    Toxicol Sci; 2004 Feb; 77(2):188-94. PubMed ID: 14657512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent transitions in mechanisms of toxicity.
    Slikker W; Andersen ME; Bogdanffy MS; Bus JS; Cohen SD; Conolly RB; David RM; Doerrer NG; Dorman DC; Gaylor DW; Hattis D; Rogers JM; Setzer RW; Swenberg JA; Wallace K
    Toxicol Appl Pharmacol; 2004 Dec; 201(3):203-25. PubMed ID: 15582645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.
    Bogdanffy MS; Daston G; Faustman EM; Kimmel CA; Kimmel GL; Seed J; Vu V
    Toxicol Sci; 2001 May; 61(1):18-31. PubMed ID: 11294970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical appraisal of existing concepts for the grouping of nanomaterials.
    Arts JH; Hadi M; Keene AM; Kreiling R; Lyon D; Maier M; Michel K; Petry T; Sauer UG; Warheit D; Wiench K; Landsiedel R
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):492-506. PubMed ID: 25108058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
    Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mode of action in relevance of rodent liver tumors to human cancer risk.
    Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
    Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunities to integrate new approaches in genetic toxicology: an ILSI-HESI workshop report.
    Zeiger E; Gollapudi B; Aardema MJ; Auerbach S; Boverhof D; Custer L; Dedon P; Honma M; Ishida S; Kasinski AL; Kim JH; Manjanatha MG; Marlowe J; Pfuhler S; Pogribny I; Slikker W; Stankowski LF; Tanir JY; Tice R; van Benthem J; White P; Witt KL; Thybaud V
    Environ Mol Mutagen; 2015 Apr; 56(3):277-85. PubMed ID: 25482136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socio-economic analysis for the authorisation of chemicals under REACH: a case of very high concern?
    Gabbert S; Scheringer M; Ng CA; Stolzenberg HC
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):564-71. PubMed ID: 25220186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.